Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Antioxidative and anti-inflammatory properties of cannabidiol
S Atalay, I Jarocka-Karpowicz, E Skrzydlewska - Antioxidants, 2019 - mdpi.com
Cannabidiol (CBD) is one of the main pharmacologically active phytocannabinoids of
Cannabis sativa L. CBD is non-psychoactive but exerts a number of beneficial …
Cannabis sativa L. CBD is non-psychoactive but exerts a number of beneficial …
[HTML][HTML] Molecular and cellular mechanisms of action of cannabidiol
Cannabidiol (CBD) is the primary non-psychoactive chemical from Cannabis Sativa, a plant
used for centuries for both recreational and medicinal purposes. CBD lacks the psychotropic …
used for centuries for both recreational and medicinal purposes. CBD lacks the psychotropic …
Cannabidiol: State of the art and new challenges for therapeutic applications
Over the past years, several lines of evidence support a therapeutic potential of Cannabis
derivatives and in particular phytocannabinoids. Δ 9-THC and cannabidiol (CBD) are the …
derivatives and in particular phytocannabinoids. Δ 9-THC and cannabidiol (CBD) are the …
Immune responses regulated by cannabidiol
JM Nichols, BLF Kaplan - Cannabis and cannabinoid research, 2020 - liebertpub.com
Introduction: Cannabidiol (CBD) as Epidiolex®(GW Pharmaceuticals) was recently
approved by the US Food and Drug Administration (FDA) to treat rare forms of epilepsy in …
approved by the US Food and Drug Administration (FDA) to treat rare forms of epilepsy in …
Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age
Background: Among the many cannabinoids in the cannabis plant, cannabidiol (CBD) is a
compound that does not produce the typical subjective effects of marijuana. Objectives: The …
compound that does not produce the typical subjective effects of marijuana. Objectives: The …
Scientific validation of cannabidiol for management of dog and cat diseases
I Corsato Alvarenga, KS Panickar… - Annual review of …, 2023 - annualreviews.org
Cannabidiol (CBD) is a non-psychotropic phytocannabinoid of the plant Cannabis sativa L.
CBD is increasingly being explored as an alternative to conventional therapies to treat …
CBD is increasingly being explored as an alternative to conventional therapies to treat …
Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: an update on current evidence and …
EP Baron - Headache: The Journal of Head and Face Pain, 2018 - Wiley Online Library
Background Comprehensive literature reviews of historical perspectives and evidence
supporting cannabis/cannabinoids in the treatment of pain, including migraine and …
supporting cannabis/cannabinoids in the treatment of pain, including migraine and …
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
S Burstein - Bioorganic & medicinal chemistry, 2015 - Elsevier
First isolated from Cannabis in 1940 by Roger Adams, the structure of CBD was not
completely elucidated until 1963. Subsequent studies resulted in the pronouncement that …
completely elucidated until 1963. Subsequent studies resulted in the pronouncement that …
An overview of cannabidiol as a multifunctional drug: pharmacokinetics and cellular effects
Cannabidiol (CBD), a non-psychoactive compound derived from Cannabis Sativa, has
garnered increasing attention for its diverse therapeutic potential. This comprehensive …
garnered increasing attention for its diverse therapeutic potential. This comprehensive …
Mitochondrial oxidative stress and “mito-inflammation”: actors in the diseases
A decline in mitochondrial redox homeostasis has been associated with the development of
a wide range of inflammatory-related diseases. Continue discoveries demonstrate that …
a wide range of inflammatory-related diseases. Continue discoveries demonstrate that …